Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL686181 | 0.91 | SCN9A (0.37) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL5557931 | 0.89 | ALDH1A1 (0.40) | SCN9AALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL686567 | 0.88 | SCN9A (0.39) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL18467219 | 0.88 | SCN9A (0.39) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL16106774 | 0.86 | SCN9A (0.39) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL5521880 | 0.86 | SCN9A (0.36) | SCN9AALDH1A1THRBMEN1KMT2A | |
| SCHEMBL12094576 | 0.81 | SCN9A (0.36) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL15463187 | 0.81 | SCN9A (0.37) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL686547 | 0.81 | MAPT (0.37) | SCN9AMAPTHPGDALDH1A1THRB | |
| SCHEMBL686909 | 0.81 | SCN9A (0.36) | SCN9AMAPTHPGDALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173353-B2 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100248135-A1 | SULFONIUM COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100248135-A1 | SULFONIUM COMPOUND | PFAS, F12, AFF1 | SCN9A 820/4885MAPT 2164/4885HPGD 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.